A Multinational Survey of Risk Factors for Infection with Extended‐Spectrum β‐Lactamase–Producing Enterobacteriaceae in Nonhospitalized Patients
Author(s) -
Ronen BenAmi,
Jesús RodríguezBaño,
Hande Arslan,
Johann Pitout,
Claudine Quentin,
Esther Calbo,
Özlem Kurt Azap,
Corinne Arpin,
Álvaro Pascual,
D. M. Livermore,
Javier Garau,
Yehuda Carmeli
Publication year - 2009
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/604713
Subject(s) - medicine , enterobacteriaceae , ciprofloxacin , microbiology and biotechnology , trimethoprim , infection control , gentamicin , antibiotics , biology , intensive care medicine , escherichia coli , biochemistry , gene
Infections caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae are increasing in frequency and are associated with high mortality rates. Circulation of CTX-M-type ESBLs in the community is of particular concern, because it may confound standard infection-control measures.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom